PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ADC Therapeutics SA (ADCT)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINCH0499880968
CUSIP049988096
SectorHealthcare
IndustryBiotechnology
IPO DateMar 16, 1979

Highlights

Market Cap$292.00M
EPS (TTM)-$2.60
Total Revenue (TTM)$52.25M
Gross Profit (TTM)$45.63M
EBITDA (TTM)-$86.34M
Year Range$0.36 - $6.04
Target Price$10.00
Short %5.19%
Short Ratio9.05

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons: ADCT vs. GERN

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in ADC Therapeutics SA, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-40.00%-30.00%-20.00%-10.00%0.00%10.00%JuneJulyAugustSeptemberOctoberNovember
-32.11%
10.27%
ADCT (ADC Therapeutics SA)
Benchmark (^GSPC)

Returns By Period

ADC Therapeutics SA had a return of 81.93% year-to-date (YTD) and 277.50% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date81.93%19.77%
1 month-8.21%-0.67%
6 months-32.13%10.27%
1 year277.50%31.07%
5 years (annualized)N/A13.22%
10 years (annualized)N/A10.92%

Monthly Returns

The table below presents the monthly returns of ADCT, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202487.95%54.81%-7.04%-1.78%-22.22%-7.87%5.06%-12.65%8.62%-10.48%81.93%
202333.07%-29.55%-45.83%-0.51%21.13%-8.51%-31.16%-18.92%-25.25%-21.96%18.57%100.00%-56.77%
2022-21.34%5.10%-12.04%-19.88%-41.89%16.23%-6.79%-7.96%-29.33%-7.88%-17.57%4.92%-80.99%
2021-10.75%-6.93%-8.20%0.53%-11.78%12.47%-13.59%38.64%-6.89%6.74%-23.21%-9.25%-36.89%
202024.62%26.68%-0.66%-5.01%-25.31%-13.03%30.05%-14.21%7.96%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current risk-adjusted rank of ADCT is 91, placing it in the top 9% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of ADCT is 9191
Combined Rank
The Sharpe Ratio Rank of ADCT is 9595Sharpe Ratio Rank
The Sortino Ratio Rank of ADCT is 9191Sortino Ratio Rank
The Omega Ratio Rank of ADCT is 8888Omega Ratio Rank
The Calmar Ratio Rank of ADCT is 9595Calmar Ratio Rank
The Martin Ratio Rank of ADCT is 8989Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for ADC Therapeutics SA (ADCT) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


ADCT
Sharpe ratio
The chart of Sharpe ratio for ADCT, currently valued at 2.67, compared to the broader market-4.00-2.000.002.002.67
Sortino ratio
The chart of Sortino ratio for ADCT, currently valued at 3.34, compared to the broader market-4.00-2.000.002.004.003.34
Omega ratio
The chart of Omega ratio for ADCT, currently valued at 1.40, compared to the broader market0.501.001.502.001.40
Calmar ratio
The chart of Calmar ratio for ADCT, currently valued at 3.34, compared to the broader market0.002.004.006.003.34
Martin ratio
The chart of Martin ratio for ADCT, currently valued at 11.04, compared to the broader market-10.000.0010.0020.0030.0011.04
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.67, compared to the broader market-4.00-2.000.002.002.67
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.55, compared to the broader market-4.00-2.000.002.004.003.55
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.50, compared to the broader market0.501.001.502.001.50
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 3.45, compared to the broader market0.002.004.006.003.45
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 17.04, compared to the broader market-10.000.0010.0020.0030.0017.04

Sharpe Ratio

The current ADC Therapeutics SA Sharpe ratio is 2.67. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of ADC Therapeutics SA with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.503.003.50JuneJulyAugustSeptemberOctoberNovember
2.67
2.67
ADCT (ADC Therapeutics SA)
Benchmark (^GSPC)

Dividends

Dividend History


ADC Therapeutics SA doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-94.08%
-2.59%
ADCT (ADC Therapeutics SA)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the ADC Therapeutics SA. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the ADC Therapeutics SA was 99.08%, occurring on Nov 9, 2023. The portfolio has not yet recovered.

The current ADC Therapeutics SA drawdown is 94.08%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.08%Jul 6, 2020845Nov 9, 2023
-7.91%May 29, 20206Jun 5, 20204Jun 11, 202010
-3.03%Jun 15, 20203Jun 17, 20202Jun 19, 20205
-1.2%Jun 24, 20202Jun 25, 20202Jun 29, 20204
-0.71%May 27, 20201May 27, 20201May 28, 20202

Volatility

Volatility Chart

The current ADC Therapeutics SA volatility is 21.84%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%JuneJulyAugustSeptemberOctoberNovember
21.84%
3.11%
ADCT (ADC Therapeutics SA)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of ADC Therapeutics SA over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for ADC Therapeutics SA.


Loading data...

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items